|Articles|October 4, 2021
BioAgilytix Announces New Partnership With CTI
Advertisement
BioAgilytix Labs, LLC, a global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development, announced that it signed a formal, worldwide partnership agreement with global contract research organization Clinical Trial and Consulting Services (CTI). The partnership enables both BioAgilytix and CTI to provide their customers with mutually complementary services.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clinical Trials in 2026: Platformization, AI Fluency, and the Redrawing of the Value Chain
2
ACT Brief: Community Sites Compete on Readiness, COA Licensing Bottlenecks Slow Start-Up, and AI’s Foundations in Pharmacovigilance
3
Breaking Out of AI Pilot Mode in Clinical Development
4
Moving Beyond Historical Site Data to Real-Time Patient Insight
5